# Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia

> **NCT00008190** · PHASE2 · COMPLETED · sponsor: **Herbert Irving Comprehensive Cancer Center**

## Conditions studied

- Leukemia

## Interventions

- **BIOLOGICAL:** aldesleukin
- **BIOLOGICAL:** filgrastim
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** etoposide
- **DRUG:** melphalan
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00008190
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** 2005-11
- **Final completion:** 2008-05
- **Target enrollment:** — (—)
- **Last updated:** 2013-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00008190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00008190, "Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00008190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*